Literature DB >> 18512165

Efficacy of Nitric Oxide in Stroke - a randomized trial. Characteristics of patients recruited in Poland.

Adam Kobayashi1, Anna Członkowska, Katarzyna Grabska, Jacek Staszewski, Jerzy Kotowicz, Laura J Gray, Philip M W Bath.   

Abstract

BACKGROUND AND
PURPOSE: High blood pressure is frequent in patients with acute stroke. It frequently returns back to normal values within the first days after onset. It is not yet established whether it requires treatment or not. The Efficacy of Nitric Oxide in Stroke (ENOS) trial aims to assess the efficacy of transdermal glyceryl trinitrate (GTN) patches versus control and stopping or continuing antihypertensive treatments in stroke. The rationale for the study is presented and characteristics of patients recruited in Poland and elsewhere compared.
MATERIAL AND METHODS: Patients were recruited to the ENOS study by 1 November, 2007. Baseline characteristics and outcome at 90 days were compared.
RESULTS: Of 783 patients overall, 78 patients were recruited in Poland. The age of the patients was similar in the two groups (70.0 vs. 69.1 years). There were fewer males among Polish patients (46.8% vs. 58.3%) and fewer intracranial haemorrhages (3.8% vs. 16.7%). There were more patients with no lesions on CT (41.8% vs. 19.3%). Polish patients more frequently had hypertension (76.0% vs. 66.4%) and subsequently more frequently had antihypertensive treatment (60.8% vs. 45.3%) and nitrates (10.1% vs. 5.0%). The number of patients independent after 3 months was similar.
CONCLUSIONS: Polish patients are slightly different from those treated in other countries, but at the moment the patient groups are too small to fully compare patient characteristics in different countries. The trial is ongoing and more centres are welcome to join.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18512165

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  2 in total

Review 1.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

2.  Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.

Authors:  Philip M W Bath; Aimee Houlton; Lisa Woodhouse; Nikola Sprigg; Joanna Wardlaw; Stuart Pocock
Journal:  Int J Stroke       Date:  2014-03-03       Impact factor: 5.266

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.